This study further confirmed that MS and AK can effectively inhibit the biosynthesis of TGs in the liver and prevent the formation of alcoholic fatty liver, as demonstrated by the results regarding SREBP-1 and ACC, as well as by the downstream regulation of the synthesis of TG. The gene discussed is SREBF1; the disease is Hepatic steatosis.